GMAB financial statements
The full income statement, balance sheet, and cash-flow statement for Genmab A/S ADS (GMAB), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
| Line item | Trend | FY2025 | FY2024 |
|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | |
| Revenue | 3.72B | — | |
| Cost of revenue | 238M | — | |
| Research & development | 1.61B | — | |
| Operating income | 1.06B | — | |
| Interest expense | 269M | — | |
| Pre-tax income | 1.20B | — | |
| Income tax | 241M | — | |
| Net income | 963M | — | |
| $7.68 | — | ||
| EPS (basic) | $7.75 | — | |
| Weighted-avg shares (basic) | 129M | — | |
| Weighted-avg shares (diluted) | 125M | — | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | |
| 2.88B-26.0% | 3.90B+86.1% | ||
| Cash & equivalents | 1.72B+24.3% | 1.38B+158.8% | |
| Accounts receivable | 1.11B+20.5% | 923M+105.7% | |
| Inventory | 18.0M+100.0% | 9.00M | |
| 12.9B+100.7% | 6.41B+182.2% | ||
| Property, plant & equipment | 153M+11.7% | 137M+285.1% | |
| Goodwill | 355M+0.0% | 355M | |
| Total non-current assets | 9.99B+297.3% | 2.51B+1315.7% | |
| Total current liabilities | 1.43B+91.8% | 744M+428.4% | |
| 7.03B+450.2% | 1.28B+676.2% | ||
| Long-term debt | 5.00B | 0.00 | |
| 5.85B+13.8% | 5.14B+143.6% | ||
| Total equity incl. non-controlling | 5.85B+13.8% | 5.14B+143.6% | |
| Common shares outstanding | 128M-2.9% | 132M+1.7% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | |
| 1.19B | — | ||
| Intangible amortization | 16.0M | — | |
| Capital expenditure | 37.0M | — | |
| Free cash flow | 1.15B | — | |
| Acquisitions | 0.00 | — | |
| Long-term debt issued | 5.50B | — | |
| Long-term debt repaid | 273M | — | |
| Common stock issued | 0.00 | — | |
| Common stock repurchased | 430M | — | |
| Dividends paid | 0.00 | — | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | |
| Market cap | 3.96B+43.2% | 2.76B-4.9% | |
| P/E | 4.1×-51.7% | 8.5×-4.9% | |
| P/S | 1.1×-69.0% | 3.4×-4.9% | |
| P/B | 0.7×+25.8% | 0.5×-61.0% | |
| P/FCF | 3.4×-76.7% | 14.8×-4.9% | |
| Earnings yield | 24.3%+107.0% | 11.8%+5.2% | |
| FCF yield | 29.0%+329.1% | 6.8%+5.2% | |
| Source filing | 20-F | 20-F |
About this data
Source: GMAB’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all GMAB filings on SEC EDGAR → Not investment advice.